Trademarkia Logo

Australia

AU$
REBLOZEL
Protected: Renewal due

Last updated on 7 Sept 2023

Owner Info

Celgene Corporation

86 Morris Avenue

Summit NJ 07901, UNITED STATES OF AMERICA

Serial Number

1718960 filed on 23 Jul 2015

Correspondent

KIRKPATRICK, SA/NV

Avenue Wolfers 32,

B-1310 La Hulpe,

BELGIUM

REBLOZEL

Classification Information


Class [005]
Pharmaceutical preparations for use in the treatment of beta thalassemia and myelodsplatic syndromes, autoinflammatory disease, autoimmune disease, bl Read More

Mark Details


Serial Number

1718960

Registered On

23 Jul 2015

Renewal On

23 Jul 2025

Mark Type

WORD

Priority Claim (Convention Details)


Date

13 Jul 2015

Mark Type

US

Legal History


Show more

Status DateAction Taken
7th Sept 2023Amendment to International Registration Contact Requested
6th May 2021Amendment to International Registration Contact Requested
25th Feb 2016IP Right Registration Published
18th Feb 2016Application Status
18th Feb 2016Register Trade Mark
10th Dec 2015IP Right Acceptance Published
27th Nov 2015Amend Status from Awaiting Advertisement
12th Oct 2015Application Accepted correspondence sent
12th Oct 2015Clear Examination report approved
12th Oct 2015User Created Notice correspondence sent